← Back to CTNM

Contineum Therapeutics, Inc. - Common stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 30/07/2026Mar 2026Filed 30/07/2026Sep 2025Filed 30/10/2025Jun 2025Filed 30/07/2026Mar 2025Filed 30/07/2026Sep 2024Filed 30/10/2025Jun 2024Filed 30/10/2025Mar 2024Filed 30/10/2025
$0$0
−$15−$14−$13−$16−$16−$10−$9−$8.4
−$0.40−$0.39−$0.45−$0.62−$0.62−$0.40−$0.39−$3.55
373728262626232.4

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.